|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 07:01PM
|
|
Re: Congestive heart failure
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 07:06PM
|
|
Re: Top Line Mid Year
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 03:38PM
|
|
Re: BIO CEO Slides Up
|
2
|
Resverlogix Corp.
|
Sep 18, 2019 07:00PM
|
|
Re: MACE Event rate,....
|
2
|
Resverlogix Corp.
|
Feb 28, 2019 04:49PM
|
|
Re: We're back on the buy-in list for Jul 05 2018
|
2
|
Resverlogix Corp.
|
Jul 05, 2018 11:11PM
|
|
Re: ACE2 and Covid
|
2
|
Resverlogix Corp.
|
Sep 25, 2020 06:29PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 24, 2020 04:20PM
|
|
Re: orphan diseases
|
2
|
Resverlogix Corp.
|
Jul 05, 2018 11:45PM
|
|
Re: MACE Event rate,....
|
2
|
Resverlogix Corp.
|
Feb 28, 2019 06:33PM
|
|
Re: BETonMACE summary from Webcast 11/18/19
|
2
|
Resverlogix Corp.
|
Nov 18, 2019 01:46PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
2
|
Resverlogix Corp.
|
Feb 05, 2022 03:11PM
|
|
Re: Contest Tally
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 04:44PM
|
|
Re: The waiting game.....
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 05:09PM
|
|
Re: What's going on in Toronto ......
|
2
|
Resverlogix Corp.
|
Feb 25, 2019 03:46PM
|
|
Presentation available
|
2
|
Resverlogix Corp.
|
Jun 10, 2020 10:47AM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 11:30AM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
2
|
Resverlogix Corp.
|
Feb 07, 2022 09:54PM
|
|
Re: Dr. Ray versus Donald McCaffrey - A huge disconnect...
|
2
|
Resverlogix Corp.
|
Nov 20, 2019 03:37PM
|
|
Re: BRD2 involvement in Covid19
|
2
|
Resverlogix Corp.
|
Mar 18, 2020 01:03PM
|
